Pharmacokinetic interactions between Telaprevir and not powered Atazanavir with ritonavir in co-infected patients with HIV and HCV genotype 1 in treatment for chronic liver disease by HCV [Interacciones farmacocineticas entre Telaprevir y Atazanavir no potenciado con ritonavir en pacientes coinfectados por el VIH y el VHC genotipo 1 en tratamiento para la hepatopatía cronica por el VHC]
Phase of Trial: Phase I
Latest Information Update: 07 Oct 2014
At a glance
- Drugs Atazanavir (Primary) ; Telaprevir (Primary)
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Mar 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 26 Mar 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01818856).